Veradigm Management
Management criteria checks 1/4
Veradigm's CEO is Tom Langan, appointed in Jun 2024, has a tenure of less than a year. directly owns 0.19% of the company’s shares, worth $1.44M. The average tenure of the management team and the board of directors is 4.8 years and 1.3 years respectively.
Key information
Tom Langan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 4.8yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price
Feb 28
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger
Nov 10Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher
Mar 06Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?
Feb 13Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 22These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well
Jan 04Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)
Dec 03Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%
Sep 28Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?
Sep 17Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist
Aug 24We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt
Jul 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | US$3m | US$476k | -US$20m |
Compensation vs Market: Insufficient data to establish whether Tom's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Tom's compensation with company performance.
CEO
Tom Langan (57 yo)
Mr. Thomas J. Langan, also known as Tom, serves as Interim Chief Executive Officer of Veradigm Inc. since June 7, 2024. He served as President at Veradigm Inc. (formerly known as Allscripts Healthcare Solu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim Chief Executive Officer | less than a year | US$2.75m | 0.19% $ 1.4m | |
| Senior VP of Marketing & Government Affairs | 4.9yrs | US$2.07m | 0.13% $ 937.6k | |
| Chief Human Resources Officer | 4yrs | US$1.33m | 0.069% $ 517.2k | |
| Interim Chief Financial Officer | 1.4yrs | no data | no data | |
| Vice President of Investor Relations | 4.3yrs | no data | no data | |
| Senior Vice President of Corporate Development & Strategy | 6.3yrs | no data | no data | |
| Senior Vice President of U.S. Hospitals & Health Systems Sales | 10.4yrs | no data | no data | |
| Senior VP & General Manager for Classic Client Solutions Business Unit | 4.8yrs | no data | no data | |
| Senior Vice President of Global Client Delivery Organization | 3.3yrs | no data | no data | |
| President of Allscripts International | 8.3yrs | no data | no data | |
| Senior VP & Corporate Secretary | no data | no data | no data | |
| Executive Director of Payer & Life Sciences Division | 6.6yrs | no data | no data |
Experienced Management: MDRX's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Lead Independent Director | 4.8yrs | US$277.33k | 0.037% $ 278.6k | |
| Independent Director | 9yrs | US$294.64k | 0.031% $ 235.2k | |
| Independent Director | less than a year | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Director | 2.3yrs | no data | 0.012% $ 92.7k | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data |
Experienced Board: MDRX's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 14:54 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Veradigm Inc. is covered by 43 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Gregory Bolan | Avondale Partners |
| Matthew Gillmor | Baird |